*Department of Investigational Cancer Therapeutics
Coronaviruses are a large family of viruses that are common in people and animals. SARS-CoV-2, a novel coronavirus, causes a respiratory disease called coronavirus disease 2019, abbreviated COVID-19.1,2 Immunocompromised patients, especially those who have cancer and undergoing treatment, pose to ...
On August 13, 2021, the Food and Drug Administration (FDA) expanded the Emergency Use Authorization for the Pfizer and Moderna COVID-19 vaccines to recommend a third dose for certain immunocompromised patients.1 This recommendation was based on data suggesting that these patients experienced ...
Avani Yenamandra, PharmD
Alice Wang, PharmD